Evidence map›Paper›PMID 25703328›Full record

ArticleOncogene2015

Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.

S Xi, S Inchauste, H Guo, J Shan, Z Xiao, H Xu, M Miettenen, M R Zhang, J A Hong, M T Raiji and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. NCancer communications (London, England) · 2021
    Review
  9. Article
  10. Review
  11. Excessive miR-25-3p maturation via NNature communications · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

S XiThoracic Surgery Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
S InchausteThoracic Surgery Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
H GuoGastrointestinal Surgery, Shandong Tumor Hospital and Institute, Jinan, Shandong Province, People's Republic of China.
J ShanAdvanced Biomedical Computing Center, SAIC-Frederick, National Cancer Institute, Frederick, MD, USA.
Z XiaoCancer and Inflammation Lab, National Cancer Institute, Frederick, MD, USA.
H XuLaboratory of Cancer Prevention, National Cancer Institute, Frederick, MD, USA.
M MiettenenPathology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
M R ZhangThoracic Surgery Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
J A HongThoracic Surgery Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
M T RaijiThoracic Surgery Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
N K AltorkiDepartment of Thoracic Surgery, Weill-Cornell University Medical Center, New York, NY, USA.
A G CassonDepartment of Surgery, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
D G BeerSection of Thoracic Surgery, University of Michigan, Ann Arbor, MI, USA.
A I RoblesLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
E D BowmanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
C C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
S M SteinbergBiostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
D S SchrumpThoracic Surgery Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
National Cancer Institute · USCenter for Cancer Research · USCornell University · USScience Applications International Corporation (United States) · USShandong Tumor Hospital · CNUniversity of Michigan–Ann Arbor · USUniversity of Saskatchewan · CA

Funding

Precision Medicine of CancerZIABC011492 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$23.2M
Epigenetic Mechanisms of Gene Expression in Thoracic MalignanciesZIABC011115 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHRUMP, DAVID · 2009 to 2025
$15.1M
Targeting the Epigenome for Lung Cancer TherapyZIASC010093 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI SCHRUMP, DAVID · 2009 to 2025
$11.9M
Epigenetic Alterations Induced by Tobacco SmokeZIABC011122 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHRUMP, DAVID · 2009 to 2013
$3.3M
Molecular Epidemiology of Human Lung CancerZ01BC005480 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 1996 to 2008
$2.3M
Intramural NIH HHS Z01 BC005480Intramural NIH HHS ZIA BC011122Intramural NIH HHS ZIA SC010093
6 · The paper itself

Abstract

Although microRNAs (miRs) have been implicated in the pathogenesis of various human malignancies, limited information is available regarding mechanisms by which these noncoding RNAs contribute to initiation and progression of tobacco-induced esophageal cancers. In this study, array and quantitative reverse transcriptase-PCR techniques were used to examine miR expression in immortalized esophageal epithelia (IEE) and esophageal adenocarcinoma (EAC) cells cultured in normal media with or without cigarette smoke condensate (CSC). Under relevant exposure conditions, CSC significantly decreased miR-217 expression in these cells. Endogenous levels of miR-217 expression in cultured EAC cells (EACC)/primary EACs were significantly lower than those observed in IEE/ paired normal esophageal tissues. RNA crosslink immunoprecipitation, quantitative reverse transcriptase-PCR (qRT-PCR) and immunoblot experiments demonstrated direct interaction of miR-217 with kallikrein 7 (KLK7), encoding a putative oncogene not previously implicated in EAC. Repression of miR-217 correlated with increased levels of KLK7 in primary EACs, particularly those from smokers. Chromatin and methylated DNA immunoprecipitation experiments demonstrated that CSC-mediated repression of miR-217 coincided with DNMT3b-dependent hypermethylation and decreased occupancy of nuclear factor 1 within the miR-217 genomic locus. Deoxyazacytidine induced miR-217 expression and downregulated KLK7 in EACC; deoxyazacytidine also attenuated CSC-mediated miR-217 repression and upregulation of KLK7 in IEE and EACC. Overexpression of miR-217 significantly decreased, whereas overexpression of KLK7 increased proliferation, invasion and tumorigenicity of EACC. Collectively, these data demonstrate that epigenetic repression of miR-217 contributes to the pathogenesis of EAC via upregulation of KLK7 and suggest that restoration of miR-217 expression may be a novel treatment strategy for these malignancies.

Indexed as

AdenocarcinomaCarcinogenesisCell Line, TumorCell ProliferationChromatinDNA MethylationDown-RegulationEpigenetic RepressionEsophageal NeoplasmsGene Expression Regulation, NeoplasticHumansKallikreinsMicroRNAsNeoplasm InvasivenessNFI Transcription FactorsSmokeChromatinKallikreinsKLK7 protein, humanMicroRNAsMIRN217 microRNA, humanNFI Transcription FactorsSmoke

Identifiers

PMID25703328
PMCPMC6301032
OpenAlexW2038164645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.